CLASS II ONGOING Device recall · Reported 5 Aug 2026 · FDA Enforcement Report

OsteoBallast, . (SeaSpine Brand) recalled by IsoTis OrthoBiologics

IsoTis OrthoBiologics is recalling OsteoBallast, . (SeaSpine Brand), distributed nationwide in the US. The recall was initiated on 2 Jul 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesREF/UDI-DI/Lots: 56800095/10889981149352/181559, 181550 02-8000-095/10889981149314/181559, 181550
Quantity recalled98

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2820-2026
FDA event ID
99332
Recalling firm
IsoTis OrthoBiologics, Irvine, CA
Classification
Class II
Status
Ongoing
Recall initiated
2 Jul 2026
FDA classified
28 Jul 2026
Reported
5 Aug 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Device type
Spinal Implants

Timeline

2 Jul 2026Recall initiated by company
28 Jul 2026Classified by FDA+26 days
5 Aug 2026Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Demineralized bone matrix (DBM) in resorbable mesh indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis, were filled with approx. 4.5 cc DBM (fill for 45 ¿ 11 mm configuration) instead of approx. 7.5 cc DBM (fill for 45 ¿ 17.5 mm configuration), which may lead to delayed fusion, incomplete fusion, pseudarthrosis, or lack of bone ingrowth.

Product as listed by the FDA

OsteoBallast, 45 x 17.5 mm (SeaSpine Brand), REF: 56800095. Ballast, 45 x 17.5 mm (IsoTis Brand), REF: 02-8000-095

Where it was distributed

US Nationwide distribution in the states of AK, NJ, TN, AR, CA, WA, OH.

Nationwide AlaskaArkansasCaliforniaNew JerseyOhioTennesseeWashington

Questions about this recall

Why was it recalled?

Demineralized bone matrix (DBM) in resorbable mesh indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis, were filled with approx. 4.5 cc DBM (fill for 45 ¿ 11 mm configuration) instead of approx. 7.5 cc DBM (fill for 45 ¿ 17.5 mm configuration), which may lead to delayed fusion, incomplete fusion, pseudarthrosis, or lack of bone ingrowth.

Which lots are affected?

REF/UDI-DI/Lots: 56800095/10889981149352/181559, 181550 02-8000-095/10889981149314/181559, 181550

Where was it sold?

US Nationwide distribution in the states of AK, NJ, TN, AR, CA, WA, OH.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from IsoTis OrthoBiologics

All 3

Other Spinal Implants recalls

All 1,157